Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters. World J Gastroenterol 2008; 14(23): 3739-3744 [PMID: 18595142 DOI: 10.3748/wjg.14.3739]
Corresponding Author of This Article
Hong-Yang Wang, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobilliary Surgery Institute, Second Military Medical University, Shanghai 200438, China. hywangk@online.sh.cn
Article-Type of This Article
Rapid Communication
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jun 21, 2008; 14(23): 3739-3744 Published online Jun 21, 2008. doi: 10.3748/wjg.14.3739
Table 1 Relationship between expressions of E-cadherin/P120 catenin and histological features of ICC n (%)
E-cadherin
P120 catenin
n
+
-
P value
+
-
P value
Differentiation grade
Well
3
3 (100)
0 (0)
0.009
3 (100)
0 (0)
0.003
Mediate
14
7 (50.0)
7 (50.0)
5 (35.7)
9 (64.3)
Poor
25
5 (20.0)
20 (80.0)
3 (12.0)
22 (88.0)
pTNM
I
2
2 (100)
0 (0)
0.035
2 (100)
0 (0)
0.004
II
9
5 (55.6)
4 (44.4)
5 (55.6)
4 (44.4)
III
25
8 (32.0)
17 (68.0)
4 (16.0)
21 (84.0)
IV
6
0 (0)
6 (100)
0 (0)
6 (100)
Table 2 Relationship between expressions of E-cadherin/P120 catenin and clinical parameters of ICC n (%)
E-cadherin
P120 catenin
n
+
-
P value
+
-
P value
Size
< 5 cm
17
7 (41.2)
10 (58.8)
0.826
6 (35.3)
11 (64.7)
0.584
5-10 cm
16
5 (31.3)
11 (68.7)
3 (18.8)
12 (81.2)
> 10 cm
9
3 (33.3)
6 (66.7)
2 (22.2)
7 (77.8)
Capsular invasion
+
6
4 (66.7)
2 (33.3)
0.164
3 (50)
3 (50)
0.391
-
36
11 (30.6)
25 (69.4)
8 (22.2)
28 (77.8)
Satellite nodules
+
11
4 (36.4)
7 (65.6)
1
3 (27.3)
8 (72.7)
0.314
-
31
11 (35.5)
20 (64.5)
8 (25.8)
23 (74.2)
Vascular invasion
+
13
2 (15.4)
11 (84.6)
0.089
1 (7.7)
12 (92.3)
0.127
-
29
13 (44.8)
16 (55.2)
10 (34.5)
19 (65.5)
L.N.P
+
7
1 (14.3)
6 (85.7)
0.39
0 (0)
7 (100)
0.161
-
35
14 (40)
21 (60)
11 (31.4)
24 (68.6)
I.M.
+
10
0 (0)
10 (100)
0.007
0 (0)
10 (100)
0.041
-
32
15 (46.9)
17 (53.1)
11 (34.4)
21 (65.6)
Table 3 Relationship between expression of E-cadherin and P120 catenin in ICC
P120
E-cadherin
+
-
P value
+
9
6
0.000
-
2
25
Table 4 Cox multivariate analysis for survival of 37 patients
Sig
RR
95% CI
Lower
Upper
E-cadherin expression
0.724
1.525
0.147
15.827
P120 expression
0.049
0.088
0.008
0.991
Differentiation
0.194
0.407
0.105
1.583
pTNM stage
0.073
2.898
0.904
9.288
Tumor size
0.037
0.387
0.159
0.944
Capsular invasion
0.052
17.046
0.981
6.166
Satellite nodules
0.709
1.597
0.137
18.578
Vascular invasion
0.948
0.961
0.284
3.247
Limph node invasion
0.087
4.72
0.8
27.855
Intrahepatic metastasis
0.786
1.352
0.154
11.899
Citation: Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters. World J Gastroenterol 2008; 14(23): 3739-3744